|
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Clinical research trials and Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus. Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus clinical trial. Subjects often receive the most expert healthcare possible for their Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus  Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
For Condition: Diabetes Mellitus, Type 2
Status: Completed
Sponsor(s): Amylin Pharmaceuticals ,
Synopsis: This is a multicenter, randomized, blinded, placebo-controlled study to assess the effects on glucose control of AC2993 as compared to placebo in patients with type 2 diabetes. Patients will be randomized into one of two AC2993 treatment arms or to placebo treatment and will continue with their required existing diabetes medications (metformin and a sulfonylurea) throughout the study.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 16 Years/75 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Subjects with Type 2 diabetes mellitus - Treated with both metformin and a sulfonylurea at defined doses for at least 3 months prior to screening - BMI= 27-45 kg/m2 - HbA1c value between 7.5% and 11% Exclusion Criteria: - Treated with oral anti-diabetic medications other than metformin and sulfonylurea within 3 months of screening - Patients treated previously with AC2993 - Patients presently treated with insulin
Total Enrollment:
Location and Contact Information:
University of Texas Health Sciences Center-Texas Diabetes Institute
San Antonio, Texas, 78207
United States
St. Lukes Roosevelt Hospital
New York City, New York, 10025
United States
North Texas Clinical Research
Irving, Texas, 75038
United States
Holston Medical Group
Kingsport, Tennessee, 37660
United States
MedResearch, Inc.
Louisville, Kentucky, 40223
United States
Lisa Abbott, MD
Reno, Nevada, 89502
United States
New Hanover Medical Research Associates
Wilmington, North Carolina, 28412
United States
OU Health Sciences Center
Oklahoma City, Oklahoma, 73104
United States
Dr. Martinez Medical Clinic
Moreno Valley, California, 92553
United States
University Primary Care Center at Belvidere
Belvidere, Illinois, 61008
United States
Mid State Endocrine Associates
Nashville, Tennessee, 37203
United States
Dallas Diabetes and Endocrinology Research Center
Dallas, Texas, 75230
United States
New Orleans Center for Clinical Research
New Orleans, Louisiana, 70119
United States
Mercury Street Medical
Butte, Montana, 59701
United States
Midwest Endocrinology Associates
Milwaukee, Wisconsin, 53215
United States
Tallahassee Endocrine Associates
Tallahassee, Florida, 32308
United States
Morton Plant Mease Health Care
Clearwater, Florida, 33756
United States
Thomas Jefferson University Diabetes Research Center
Philadelphia, Pennsylvania, 19107
United States
Baptist Diabetes Associates
Miami, Florida, 33176
United States
Extended Arm Physicians/ Southern Drug
Montgomery, Alabama, 36106
United States
Coastal Carolina Research Center
Mt. Pleasant, South Carolina, 29464
United States
American Health Network
Indianapolis, Indiana, 46222
United States
West Olympia Internal Medicine
Olympia, Washington, 98502
United States
Southern Drug Research Network
Tallassee, Alabama, 36078
United States
Illinois Center for Clinical Trials
Chicago, Illinois, 60610
United States
Comprehensive NeuroScience Inc.
Sarasota, Florida, 34232
United States
Radiant Research-Columbus
Columbus, Ohio, 43212
United States
Radiant Research
Portland, Oregon,
United States
Grand Rapids Associated Interns
Grand Rapids, Michigan,
United States
University of Mississippi Medical Center
Jackson, Mississippi, 39216
United States
UNC Diabetes Care Center
Durham, North Carolina, 27713
United States
Whittier Institute for Diabetes
La Jolla, California, 92037
United States
Lovelace Scientific Resources-Las Vegas
Las Vegas, Nevada, 89102
United States
Medical Group of Encino
Encino, California, 91436
United States
Physicians for Clinical Research
Camp Hill, Pennsylvania,
United States
Indiana University Outpatient Clinical Research
Indianapolis, Indiana,
United States
Diabetes and Endocrinology Specialists
Chesterfield, Missouri, 63017
United States
University of Colorado-Barbara Davis Center for Childhood Diabetes
Denver, Colorado, 80262
United States
DOCS at Beth Israel Medical Center
Yonkers, New York, 10710
United States
Ochsner Clinic
New Orleans, Louisiana, 70121
United States
Clinical Research of West Florida, Inc.
Clearwater, Florida, 33765
United States
Medical Arts Research Collaborative
Excelsior Springs, Missouri, 64024
United States
University of Maryland-Joslin Diabetes Center
Baltimore, Maryland, 21012
United States
Lipid, Atherosclerosis & Metabolic Clinic
Kansas City, Kansas, 66160
United States
Rockwood Clinic
Spokane, Washington, 99202
United States
Medical Research Unlimited
Aventura, Florida,
United States
Utah Diabetes Center at the University of Utah
Salt Lake City, Utah, 84108
United States
Creekside Endocrine Associates
Denver, Colorado, 80209
United States
Israel A. Hartman, M.D.
Arlington, Texas, 76014
United States
Charlotte Clinical Research
Charlotte, North Carolina, 28211
United States
Columbus Metabolic Foundation
Columbus, Georgia, 31901
United States
Pinnacle Research Group
Anniston, Alabama, 36207
United States
Advanced Clinical Research Institute
Anaheim, California, 92801
United States
Henry Ford Health System
Detroit, Michigan,
United States
Medstar Clinical Research
Washington D.C., District of Columbia, 20003-4393
United States
Medford Medical Clinic
Medforo, Oregon, 97504
United States
Clinica Research Inc.
Waltham, Massachusetts, 02154
United States
Kentucky Diabetes Center
Lexington, Kentucky, 40503
United States
Mid Missouri Research Specialists, Inc.
Rolla, Missouri, 65401
United States
Salt Lake Research
Salt Lake City, Utah, 84124
United States
International Diabetes Center
Minneapolis, Minnesota, 55416
United States
Physicians Group Research Clinic, LLC
Little Rock, Arkansas, 72205
United States
University of Wisconsin West Clinic
Madison, Wisconsin, 53711
United States
Metabolic Research Institute, Inc.
West Palm Beach, Florida, 33401
United States
Northeast Florida Endocrine & Diabetes Research
Jacksonville, Florida, 32204
United States
SAM Clinical Research
San Antonio, Texas, 78229
United States
Albert Einstein Medical Center
Philadelphia, Pennsylvania, 19141
United States
Cook County Hospital
Chicago, Illinois, 60612
United States
St. Joseph Heritage Healthcare
Fullerton, California, 92835
United States
Comprehensive Diabetes-Endocrine Medical Associates
Redwood City, California, 94062
United States
The Endocrine Clinic
Memphis, Tennessee, 38119
United States
Central Kentucky Research Associates
Lexington, Kentucky, 40509
United States
St Lukes Lipid and Diabetes Research Center
Kansas City, Missouri, 64111
United States
Unifour Medical Research
Hickory, North Carolina, 28601
United States
East Bay Clinical Trial Center
Concord, California,
United States
University Mednet
Mentor, Ohio, 44060
United States
Radiant Research-San Diego
San Diego, California, 92108
United States
Parkway Medical Center
Birmingham, Alabama, 35206
United States
First Care Family Doctors
Fayetteville, Arkansas, 72701
United States
Richard Cherlin, M.D.
Los Gatos, California, 95032
United States
Diabetes and Glandular Disease Clinic
San Antonio, Texas, 78229-3894
United States
Jupiter Research Institute
Jupiter, Florida, 33458
United States
Texas Tech University Health Sciences-Internal Medicine
El Paso, Texas, 79905
United States
University of Kentucky Metabolic Research Group
Lexington, Kentucky, 40536-9841
United States
Radiant Research-St. Louis
St. Louis, Missouri, 63141
United States
Midwest Pharmaceutical Research
St. Peters, Missouri, 63376
United States
Valley Research
Fresno, California, 93720
United States
Internal Medicine Associates
Ft. Myers, Florida,
United States
Medical Associates of Northern Virginia
Arlington, Virginia, 22204
United States
George Washington University
Washington D.C., District of Columbia, 20037
United States
Rochester Clinical Research
Rochester, New York, 14609
United States
SUNY Downstate
Brooklyn, New York, 11203
United States
Medical University of South Carolina
Charleston, South Carolina, 29425
United States
Philadelphia Health Associates
Philadelphia, Pennsylvania, 19146
United States
Diablo Clinical Research
Walnut Creek, California,
United States
CNS Clinical Trials
Chester, South Carolina, 29706
United States
University of Hawaii-Diabetes Research Group
Ewa Beach, Hawaii, 96706
United States
Clin Sci International
Gainesville, Florida, 32605
United States
Veterans Medical Research Foundation
San Diego, California, 92161
United States
Northwestern Memorial Physicians Group
Chicago, Illinois, 60602
United States
Additional Information:
Study ID Numbers: 2993-115;
Study Start Date:
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00035984
Other Diabetes Mellitus, Type 2 Studies:
1. Evaluation of the Bioavailability of Pramlintide
2. Exenatide Compared with Twice-Daily Biphasic Insulin Aspart in Patients with Type 2 Diabetes Using Sulfonylurea and Metformin
3. Randomized Trial of Health Events Costs in Diabetic Blacks
4. Effect of AC2993 Compared with Insulin Glargine in Patients with Type 2 Diabetes Also Using Combination Therapy with Sulfonylurea and Metformin
5. Evaluating "Health at Every Size"(HAES) as an Alternative Obesity Treatment Model
Related Studies:
Other Diabetes Mellitus, Type 2 Clinical Trials
Other Massachusetts Clinical Trials
Other Waltham Clinical Trials
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
|
|
|
|
|
|
|
|
